Table 1.

Plasma and tissue concentrations (fmol/mg wet weight) of catechols in control subjects (CON, means ± SEM) and the patient with multiple system atrophy (MSA). Numbers in parentheses are numbers of subjects.

Plasma	CON	MSA Patient	% Of CON
NE Supine	1.64 ± 0.09 (62)	1.02	62%
NE Upright	3.39 ± 0.27 (26)	1.20	35%
CSF NE	0.90 ± 0.07 (32)	0.28	31%
CSF DOPAC	2.37 ± 0.22 (32)	1.26	53%
CSF DHPG	11.02 ± 0.57 (32)	9.78	89%
Putamen	CON	MSA Patient	% Of CON
DOPA	1597 ± 383 (25)	471	29%
DA	16,848 ± 2019 (25)	500	8.9%
DOPAL	339 ± 24 (24)	36	3.4%
DOPAC	2616 ± 460 (24)	54	1.6%
NE	198 ± 26 (25)	17.9	31%
DHPG	14.6 ± 2.3 (24)	0.9	5.6%
Myocardium
DOPA	219 ± 28 (23)	275	126%
DA	72.5 ±15.6 (23)	7.9	10.9%
DOPAL	Not detected	Not detected
DOPAC	35.6 ± 7.1 (23)	3.6	10.1%
NE	1540 ± 247 (23)	3.3	0.2%
DHPG	90.5 ± 19.5 (23)	0.6	0.7%